Ervebo
As listed in the register: Ervebo, Injektionslösung
·
- Prescription only
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- RVSVdeltaG-ZEBOV-GP vivus attenuatum
- Made by
- MSD Merck Sharp & Dohme AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Ervebo ist indiziert für die aktive Immunisierung von Personen ab 1 Jahr zum Schutz vor der Ebola-Viruskrankheit (EVD [Ebola Virus Disease]), die durch das Zaire-Ebola-Virus verursacht wird.
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | MSD Merck Sharp & Dohme AG |
|---|---|
| Active substance | RVSVdeltaG-ZEBOV-GP vivus attenuatum |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07BX02 · Antibiotics, antivirals and antifungals taken into the body |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Ervebo, Injektionslösung |
| Packs | 10 Durchstechflasche(n) |
| Zulassungsnummer | 68358 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.